Aeterna Zentaris receives grant to develop cytotoxic conjugates and related diagnostic tools March 29, 2011
FDA requests further survival data for Oxigene's Zybrestat in anaplastic thyroid cancer March 28, 2011
Mersana Therapeutics initiates phase Ib extension of XMT-1001 in gastric cancer and NSCLC March 28, 2011
GSK withdraws regulatory applications for dutasteride for prostate cancer risk reduction March 28, 2011
Oncolytics Biotech completes enrollment in phase II Reolysin trial in head and neck cancers March 25, 2011
RSS